Vincenzo Minotti - Divisione di Oncologia Medica

基本信息

浏览量：36

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 54 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Met Inhibitor Capmatinib Plus Egfr Tyrosine Kinase Inhibitor Nazartinib For Egfr-Mutant Non-Small Cell Lung Cancer

E. Felip,V. Minotti,R. Soo,J. Wolf,B. Solomon,D. S. W. Tan,A. Ardizzoni,D. H. Lee,L. V. Sequist,F. Barlesi,L. Paz-Ares,D. Rodriguez-Abreu,

ANNALS OF ONCOLOGY（2020）

引用7浏览0引用

1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer

E. Felip,V. Minotti,R. Soo,J. Wolf,B. Solomon,D.S.W. Tan,A. Ardizzoni,D.H. Lee,L.V. Sequist,F. Barlesi,L. Paz-Ares,D. Rodriguez-Abreu,

Annals of Oncology（2020）

引用7浏览0引用

Detection Of Egfr Mutations In Plasma Cell-Free Tumor Dna Of Tki-Treated Advanced-Nsclc Patients By Three Methodologies: Scorpion-Arms, Pnaclamp, And Digital Pcr

Annamaria Siggillino,Paola Ulivi,Luigi Pasini,Maria Sole Reda,Elisa Chiadini,Francesca Romana Tofanetti,Sara Baglivo,Giulio Metro,Lucio Crinó,Angelo Delmonte,Vincenzo Minotti,Fausto Roila,

DIAGNOSTICS（2020）

引用0浏览0WOS引用

Immune Gene Expression And Bayesian Network Analysis In Advanced Non Small Cell Lung Cancer (Nsclc) Patients Treated With Immunotherapy

Sara Baglivo,Fortunato Bianconi,Francesca Romana Tofanetti, Biagio Ricciuti,Lorenza Pistola,Annamaria Siggillino, Maria Sole Reda, Clelia Mencaroni, Maria Francesca Currà, Valeria Teti,Giulio Metro,Guido Bellezza,

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用1浏览0引用

P1.01-65 Immune Gene Expression, Bayesian Network and Genetic Mutation Analysis in Advanced NSCLC Patients Treated with Immunotherapy

S. Baglivo,F. Bianconi,F. Tofanetti,B. Ricciuti,L. Pistola,A. Siggillino, M. Reda,G. Metro,G. Bellezza,V. Minotti,F. Roila,V. Ludovini

JOURNAL OF THORACIC ONCOLOGY（2019）

引用0浏览0引用

P2.04-49 Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial

L. Landi,L. Bonanno,A. Delmonte,M. Papi, V. Stati,V. Minotti,C. Bennati, F. D'Incà,M. Migliorino,S. Gori,A. Santo,F. Piantedosi,

JOURNAL OF THORACIC ONCOLOGY（2019）

引用0浏览0引用

1595TiPNivolumab plus ipilimumab (NI) versus chemotherapy plus nivolumab (CN) in squamous cell lung cancer (SqCLC): The SQUINT trial

L Landi, L Bonanno, A Delmonte, P Maximilian, V Stati,V Minotti, C Bennati, F D’Incà,M R Migliorino,S Gori,A Santo,F Piantedosi,

ANNALS OF ONCOLOGY（2019）

引用0浏览0引用

P3.02c-068 Immunotherapy against Non-Small Cell Lung Cancer (NSCLC): Looking for Predictive Factors to Avoid an Untargeted Shooting: Topic: IT Biomarkers

Luca Paglialunga,Guido Bellezza,Alessio Gili,Biagio Ricciuti,Vincenzo Minotti,Rita Chiari,Giulio Metro,Vienna Ludovini, Roberta Matocci, Daniela Colabrese,Sara Baglivo,Lucio Crinò,

Journal of Thoracic Oncology（2017）

引用0浏览0引用

Quantification and Monitoring of Treatment Response in EGFR Mutant NSCLC Patients by Digital-PCR in Plasma cftDNA

Vienna Ludovini,Annamaria Siggillino, Maria Sole Reda,Fortunato Bianconi,Rita Chiari,Sara Baglivo,Lorenza Pistola,Francesca Romana Tofanetti, Roberta Matocci, Clelia Mencaroni,Giulio Metro,Chiara Bennati,

JOURNAL OF THORACIC ONCOLOGYno. SUP1 (2017): S1189-S1190

引用0浏览0引用

Immunotherapy against Non-Small Cell Lung Cancer (NSCLC): Looking for Predictive Factors to Avoid an Untargeted Shooting

Luca Paglialunga,Guido Bellezza,Alessio Gili,Biagio Ricciuti,Vincenzo Minotti,Rita Chiari,Giulio Metro,Vienna Ludovini, Roberta Matocci, Daniela Colabrese,Sara Baglivo,Lucio Crino,

JOURNAL OF THORACIC ONCOLOGYno. SUP1 (2017): S1317-S1318

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn